Clinical Trials Directory

Trials / Completed

CompletedNCT02505854

Influence of Probiotic and Symbiotic in Body Weight, Blood Sugar and Lipemia of Obese Women

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Universidade Federal do Rio de Janeiro · Academic / Other
Sex
Female
Age
25 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate whether gut microbiota modulation by probiotic and symbiotic contribute with weight loss and improvement of metabolic parameters in women with obesity.

Detailed description

We will evaluate the effects of probiotic and symbiotic on weigh loss, blood glucose, lipid profile, metabolomic profile, and gut microbiota composition variables in women with obesity.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTProbioticHypocaloric diet associated with capsule containing 1billion UFC Bifidobacterium lactis and sache of maltodextrin
DIETARY_SUPPLEMENTSymbioticHypocaloric diet associated with capsule containing 1billion UFC Bifidobacterium lactis and sache of fructooligosaccharide
DIETARY_SUPPLEMENTPlaceboHypocaloric diet associated with capsule containing 50g of gelatin and sache of maltodextrin

Timeline

Start date
2015-07-01
Primary completion
2016-12-01
Completion
2018-11-01
First posted
2015-07-22
Last updated
2019-12-10

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02505854. Inclusion in this directory is not an endorsement.